Introduction
Solar retinopathy is a rare ophthalmic disorder resulting from sustained view of the sun without protective eyewear. Symptoms are typically bilateral and are characterized by blurred vision, various patterns of scotoma, chromatopsia, headache, and photosensitivity. 1, 2 Though rare, numbers of patients presenting with solar retinopathy typically increase following a solar eclipse. [2] [3] [4] [5] [6] [7] Retinal injury as a result of unprotected sungazing occurs in the photoreceptor cells of the fovea and parafovea. It has been suggested that damage occurs secondarily to the disruption of photoreceptor outer segment membranes and mitochondria by oxidative damage as a result of electromagnetic radiation. 3, 8 High definition spectral domain optical coherence tomography (OCT), fluorescein angiography (FA), fundoscopy, and various visual acuity and contrast sensitivity tests are used to determine the severity of retinal damage. [1] [2] [3] [4] [5] [6] [7] 9 The vast majority of symptoms resolve within 1-3 months, but there are several documented cases of achromatopsia, central scotoma, and decreased visual acuity remaining 7 months to 1 year after exposure. 7, 10 On August 21st, 2017 a solar eclipse occurred within the view of the entire continental USA. The local academic ophthalmology clinic held several press conferences teaching about eye safety during the solar eclipse. There were also numerous print, radio and news reports that resulted from these press conferences. There was a high concern for counterfeit safety glasses and Amazon.com initiated a recall of many suspect glasses.
11
Data regarding cases of solar retinopathy as a result of this eclipse is still limited. The aim of our case study is to explore all cases of solar retinopathy that presented after the 2017 solar eclipse in Utah. This data will be used to develop a better understanding of 
Materials and methods
After approval was obtained from the University of Utah Institutional Review Board (IRB) Committee, patients with solar retinopathy secondary to sun gazing during the solar eclipse in August 2017 were found for this report through a short survey sent to 92% of ophthalmologists in Utah; there were approximately 135 surveys sent. The survey asked how many patients were seen with complaints of vision changes after the solar eclipse, how many patients had exam findings consistent with solar retinopathy, and if we could contact the provider to request the patient's chart. If a provider did not respond, it was assumed that he or she did not have any cases of solar retinopathy. Not all charts were available for review. Once available charts were obtained, they were evaluated for the following criteria where applicable and available: age, gender, chief complaint, visual acuity, exam findings, OCT findings (CIRRUS™, Carl Zeiss Meditec, Dublin, CA, USA; SPECTRALIS ® , Heidelberg Engineering, Franklin, MA, USA), FA findings, if eye protection was worn, if the eye protection worn was properly certified, time spent looking at the sun without eye protection, if pain was associated with the symptoms, if the symptoms resolved, and if there were any other eye problems.
Ethics approval
This study was done under IRB# 105,746 through the University of Utah and meets standards set by the Declaration of Helsinki. The University of Utah IRB did not feel that patient consent was required due to the fact that this study was done with de-identified information as a retrospective chart review and only one patient was available for follow up. Appropriate measures were taken to ensure patient data confidentiality.
Results
Of the 135 surveys sent out, 38 physicians responded. These 38 physicians reported 27 patients that had presented with concern for vision changes after the solar eclipse. Of these 27, six patients had exam findings consistent with solar retinopathy. Of these six cases, charts were available for three cases. These three cases are presented below.
Case 1
A 17-year-old male presented 24 hours after the eclipse with complaints of bilateral central scotoma after direct visualization of the eclipse for 15 seconds, three separate times. The 
Case 2
A 36-year-old-male presented 8 days after the eclipse with bilateral central scotoma with no eye pain. He stated that onset of symptoms began the day of the eclipse and were accompanied by a headache that had since subsided. The 
Discussion
Despite millions of people across Utah viewing the solar eclipse on August 21, 2017, very few people were found to have ophthalmic damage from the solar eclipse. This can be attributed to effective education about the risks and ready access to eye protection. As far as the authors of this paper know, no one in Utah had eye damage from faulty solar eclipse viewing glasses. The one exception being the man in Case 2, as the certification status of his solar eclipse viewing glasses was unknown. All of the patients in the cases mentioned previously did not use safety glasses when they viewed the eclipse, which led directly to the development of solar retinopathy. The common finding in all cases was a central scotoma with a correlating change to the IS/OS junction on OCT. Changes in IS/OS junctions are typically caused by disruption of photoreceptor cells. This corresponds well with data suggesting that electromagnetic radiation contributes to photoreceptor damage through inducing oxidative damage. 3, 8 Demographically, all cases available and presented in this series were young males. The weaknesses of this case series include the lack of follow up information and the unavailability of patient records on three of the six confirmed cases of solar retinopathy. Our data possibly underestimates the incidence of solar retinopathy resulting from unprotected eclipse viewing as we cannot account for those patients with symptoms that chose to forego medical attention. Physicians that did not respond to the survey may have also provided more patient data. It is unknown what the prevalence of solar retinopathy is during a non-solar eclipse year. The next total solar eclipse will be July 2, 2019, visible from the South Pacific and South America. It will be important to continue the public education efforts that were seen in preparing for the Great American Solar Eclipse.
Conclusion
Although rare, solar retinopathy is highly preventable with education efforts. This case series provides insight into the rise in prevalence of cases following a solar eclipse, and populations at the greatest risk. Data can be used to tailor education programs.
